LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that Cadmus Rich, MD, MBA, Vice President, Medical Affairs and Clinical Development, will present at GTCbio’s 8th Ocular Diseases and Drug Discovery Conference. The presentation, “Modulation of IOP by Adenosine Mimetics: A New Ocular Drug Target,” will take place on March 21, 2016 at 4:55pm PT at The Westin San Diego in San Diego, California.
